DENTSPLY SIRONA Inc.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

XRAY$9.54+0.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(in millions, except per share amounts)

	Three Months Ended September 30,		Nine Months Ended September 30,
	2026	2025	2026	2025
Net sales	$836	$904	$2,614	$2,719
Cost of products sold	393	463	1,251	1,322
Gross profit	443	441	1,363	1,397
Selling, general, and administrative expenses	363	355	1,078	1,055
Research and development expenses	42	37	131	110
Goodwill and intangible asset impairments	3	262	3	497
Restructuring and other (income) expenses	(2)	5	67	18
Operating income (loss)	37	(218)	84	(283)
Other income and expenses:
Interest expense, net	25	23	71	66
Other income, net	(14)	(11)	(43)	(10)
Income (loss) before income taxes	26	(230)	56	(339)
Provision for income taxes	29	198	33	114
Net (loss) income	(3)	(428)	23	(453)
Less: Net loss attributable to noncontrolling interest	(1)	(1)	(2)	(1)
Net (loss) income attributable to Dentsply Sirona	$(2)	$(427)	$25	$(452)
(Loss) earnings per common share attributable to Dentsply Sirona:
Basic	$(0.01)	$(2.14)	$0.12	$(2.27)
Diluted	$(0.01)	$(2.14)	$0.12	$(2.27)
Weighted average common shares outstanding:
Basic	199.2	199.5	199.6	199.3
Diluted	199.2	199.5	200.6	199.3

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.